Filter:
“Thank you to the Alpha-1 patients that participated in this important clinical trial, InnovAATe. It is because of the dedication of patients […]
Read More… from Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial
Mark Your Calendars! Medicare Open Enrollment happens from October 15th – December 7th and is the time each year when […]
Read More… from 2026 Medicare Open Enrollment Webinar For Alphas
The Alpha-1 Foundation’s (A1F) 30th anniversary was nothing short of inspirational at the American Lung Association’s (ALA) Escape to The […]
It is important for Alphas to be up-to-date on their seasonal vaccines. AlphaNet has provided a chart to keep you […]
Read More… from Guidance for Alphas on Adult Seasonal Respiratory Vaccines
Early September, Alpha-1 Foundation (A1F) advocates from across the country gathered in Washington, DC, for a Lobby Day bringing the […]
Read More… from Alphas Go to Washington, DC: Momentum Builds for Home Infusion and Oxygen Access
The Alpha-1 Foundation proudly joins the broad coalition of more than 200 organizations endorsing the Safe Step Act and stand […]
Read More… from A1F Endorses Safe Step Act Patient Protection Bill
Below is the official letter addressed to key leaders in the U.S. Senate and House of Representatives urging support for […]
Read More… from A1F Joins Advocacy Groups in Signing Congressional Letter on Rare Pediatric Program
Because of COVID-19’s impacts on the lungs, the U.S. Alpha-1 Foundation has provided detailed, specific guidance for patients who have alpha […]
Read More… from Coronavirus: Alpha 1 Group Gives Specific Guidance for Patients
Shortly after the FDA granted an Emergency Use Authorization to its first commercially developed coronavirus test—developed by Roche for use […]
For many immunocompromised people, social distancing isn’t a new endeavor. Alpha-1 Antitrypsin Deficiency is sometimes called an “invisible disability”. This […]
https://www.alpha1.org/alphas-friends-family/resources/clinical-trials/ A clinical trial is a research study in which one or more human subjects are prospectively assigned to one […]
Recent international reports have highlighted the emergence of a new coronavirus in Wuhan, Hubei Province, China. The 2019 Novel Coronavirus […]
Read More… from 2019 Novel Coronavirus (2019-nCoV) and Plasma Protein Therapies
Miami, January 31, 2020 – The Alpha-1 Foundation is proud to celebrate its 25th Anniversary. On January 31, 1995, the […]
Read More… from The Alpha-1 Foundation celebrates its 25th anniversary
The Alpha-1 Foundation is proud to report that multinational pharmaceutical manufacturer Grifols also received approval by the Danish Medicines Council […]
Read More… from Grifols’s Prolastina approved for use in Denmark
Miami, Jan. 13, 2020 – Jonathan Maidment will return to the trails again in 2020! He is pleased to announce […]
Read More… from Jonathan Maidment goes for the Triple Crown of Hiking
Cold weather conditions can worsen symptoms for lung affected Alphas and for patients with chronic obstructive pulmonary disease (COPD), as […]
Read More… from Q&A: Alphas, seasonal flu and winter wellness
Celebrate Irish Heritage by observing St. Patrick’s Day with friends and family to benefit Alpha-1 research and programs! Enjoy the […]
